Craft

Innovotech

Stock Price

$0.1

2024-10-29

Market Capitalization

$5.1 M

2024-10-29

Revenue

$4.5 M

FY, 2025

Innovotech Summary

Company Summary

Overview
Innovotech is a biotechnology company that specializes in biofilm product development. Its products include MBEC Assay, a biofilm growth device, bioFILM PA, a diagnostic kit to assist physicians in the selection of antibiotic treatment of patients with a biofilm-based chronic lung infection, and InnovoSCEPT, a veterinary kit designed to determine antibiotic treatment for infections in both large and small animals. The company caters to the medical, agricultural, and industrial sectors.
Type
Public
Status
Active
Founded
2003
HQ
Edmonton, CA | view all locations
Website
https://www.innovotech.ca
Cybersecurity rating
Sectors

Key People

  • James Timourian, Director, Chairman

  • Patricia Nadworny

    Patricia Nadworny, Chief Scientific Officer & Quality and Safety Director

  • David S. Tam, Director

    • Tyler Boone

      Tyler Boone, Chief Operating Officer

    LocationsView all

    1 location detected

    • Edmonton, AB HQ

      Canada

      Suite L131, 2011-94 Street

    Innovotech Financials

    Summary Financials

    Revenue (FY, 2025)
    $C4.5M
    Gross profit (FY, 2025)
    $C2.8M
    Net income (FY, 2025)
    $C88.0K
    Cash (FY, 2025)
    $C1.6M
    EBIT (FY, 2025)
    $C112.0K
    Enterprise value
    $3.6M

    Footer menu